Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Phio Pharmaceuticals Corp (PHIO)

24 + Investors. Track Smart Money conviction in PHIO. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +7
Streak
2Q ▲
Buyers last Q
73%

Smart Money Signals — PHIO

Based on 24 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added PHIO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
24 hedge funds hold PHIO right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +140% more funds vs a year ago

fund count last 6Q
+14 new funds entered over the past year (+140% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 73% buying

19 buying7 selling
Last quarter: 19 funds were net buyers (14 opened a brand new position + 5 added to an existing one). Only 7 were sellers (0 trimmed + 7 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+6 vs last Q)

new funds entering per quarter
Funds opening a new PHIO position: 4 → 3 → 8 → 14. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 62% entered in last year

4% conviction (2yr+) 33% medium 62% new
Only 1 funds (4%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +107% but shares only +84% — price-driven

Value
+106%
Shares
+83%
Last quarter: the total dollar value of institutional holdings rose +107%, but actual share count only changed +84%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

3 → 4 → 3 → 8 → 14 new funds/Q
New funds entering each quarter: 4 → 3 → 8 → 14. A growing number of institutions are discovering PHIO each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🌱

Early stage — 67% of holders entered in last year

4% veterans 29% 1-2yr 67% new
Of 24 current holders: 16 (67%) entered in the past year, only 1 (4%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 50% AUM from top-100 funds

50% from top-100 AUM funds
6 of 24 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in PHIO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
6.4
out of 10
Moderate Exit Risk
Exit risk score 6.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PHIO

In 2026 Q1, 19 hedge funds were net buyers of PHIO (14 opened a new position, 5 added to an existing one), while 7 reduced or exited (7 sold completely) — a 73% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 50% of total institutional value in PHIO is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +7 funds (more new holders than closures). Total institutional holders: 24.

Hedge Fund Ownership: PHIO

How many hedge funds hold PHIO — quarterly history vs. share price
Quarterly hedge fund ownership of PHIO vs. share price

Market Analysis: PHIO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PHIO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Phio Pharmaceuticals Corp (PHIO) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much PHIO has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 82d ago
PHIO
-15.6%
XLV
+705.0%

PHIO outperformed XLV by -720.6% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 37d ago
PHIO
-3.7%
XLV
+691.9%

Since the filing became public, PHIO outperformed XLV by -695.6% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

3 top-rated funds 0 high-conviction
Consensus
2.6
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: PHIO
24 + Investors

Track Smart Money conviction in PHIO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 24 17 41.18%
13F Shares 668K 364K 83.73%
Total Value $791K $382K 106.89%
New Positions 14 8 +6
Increased Positions 5 5 -
Closed Positions 7 2 +5
Reduced Positions 0 0 -
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: PHIO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

24 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PHIO. Verified SEC 13F-HR filings.

QUARTER:
Top 21 PHIO holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Scientech Research LLC 0.03% 30,032 $37K
2 Two Sigma Securities, LLC 0.00% 15,224 $19K
3 XTX Topco Ltd 0.00% 24,868 $30K
4 Tower Research Capital LLC (TRC) 0.00% 7,620 $9K
5 Hrt Financial LP 0.00% 34,732 $42K
6 Nbc Securities, INC. 0.00% 1,074 $1K
7 Spire Wealth Management 0.00% 2,000 $2K
8 Cetera Investment Advisers 0.00% 45,000 $55K
9 SBI Securities Co., Ltd. 0.00% 1,224 $1K
10 Two Sigma Investments, LP 0.00% 32,495 $40K
11 Captrust Financial Advisors 0.00% 10,000 $12K
12 Jane Street Group, LLC 0.00% 119,189 $145K
13 Vanguard Fiduciary Trust Co 0.00% 38,169 $47K
14 UBS Group AG 0.00% 26,987 $33K
15 Osaic Holdings, INC. 0.00% 2,000 $2K
16 Vanguard Capital Management LLC 0.00% 79,853 $97K
17 Activest Wealth Management 0.00% 9
18 Caitong International Asset Management Co., Ltd 0.00% 3
19 Citigroup Inc 0.00% 1,025 $1K
20 Morgan Stanley 0.00% 6,000 $7K
21 Assetmark, Inc 0.00% 110
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Phio Pharmaceuticals Corp (PHIO)

What does the Smart Money Trend signal show for PHIO?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added PHIO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for PHIO?

More buyers than sellers — 73% buying: Last quarter: 19 funds were net buyers (14 opened a brand new position + 5 added to an existing one). Only 7 were sellers (0 trimmed + 7 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for PHIO holders?

Elite ownership — 50% AUM from top-100 funds: 6 of 24 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in PHIO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held PHIO?

Mostly new holders — 62% entered in last year: Only 1 funds (4%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Phio Pharmaceuticals Corp (PHIO) following the 2026 Q1 hedge fund 13F filings?

As of today, PHIO has moved -3.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +691.9% for the XLV sector ETF — an outperformance of -695.6%. Since the quarter end (March 31, 2026), PHIO has gained -15.6% vs +705.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →